Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials

Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials

Resource Type

ECFS Guideline

References

Journal of Cystic Fibrosis Volume 10 (2011) S79-S81

Document

PDF icon Available as a free download here [1]

Keywords

Pulmonary exacerbation [2]
clinical trials [3]
EuroCareCF [4]
outcome parameters [5]
intravenous antibiotics [6]
oral antibiotics [7]
nebulised therapy [8]

Date

Wednesday, June 1, 2011

Featured resource article

Yes

Resource - Guideline Type

EuroCareCF - Workpackage 3 - Coordination of Clinical Research [9]
Source URL:https://www.ecfs.eu/resource-article/ecfs-guideline/pulmonary-exacerbation-towards-definition-use-clinical-trials-report

Links
[1] https://www.ecfs.eu/sites/default/files/publications-ecfs-guidelines/JCF10_Sup2_S79_S81.pdf [2] https://www.ecfs.eu/research-article-keywords/pulmonary-exacerbation [3] https://www.ecfs.eu/research-article-keywords/clinical-trials [4] https://www.ecfs.eu/research-article-keywords/eurocarecf [5] https://www.ecfs.eu/research-article-keywords/outcome-parameters [6] https://www.ecfs.eu/research-article-keywords/intravenous-antibiotics [7] https://www.ecfs.eu/research-article-keywords/oral-antibiotics [8] https://www.ecfs.eu/research-article-keywords/nebulised-therapy [9] https://www.ecfs.eu/resource-guideline-type/eurocarecf-workpackage-3-coordination-clinical-research